Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in
the United States. One hundred fifty (150) subjects diagnosed with gastroparesis, who satisfy
the selection criteria for the study, will be randomized to one of two treatment groups,
active or placebo.